Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-21

Clinical Trial Update: Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity [NA]

View source ↗

Summary

Clinical trial update: Mazdutide is being studied as adjuvant therapy after sleeve gastrectomy in people with severe obesity; the recruitment status is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mazdutide (Mazdutide)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Severe Obesity | NA | Status: NOT_YET_RECRUITING